Renin-angiotensin-aldosterone system and migraine: A systematic review of human studies

Karina Lúcia Moreira Sassi, Laís Bhering Martins, Aline Silva de Miranda, Antonio Lucio Teixeira

Producción científica: Review articlerevisión exhaustiva

7 Citas (Scopus)

Resumen

Migraine is a common neurologic condition marked by recurrent episodes of headache. Its pathophysiology is highly complex involving neuronal, inflammatory and vascular mechanisms. The Renin-Angiotensin System (RAS) can modulate all these mechanism, being a potential pharmacological target for migraine treatment. We carried out a systematic review of the studies evaluating the involvement of RAS in patients with migraine. There is evidence from genetic studies exploring the relation between migraine and RAS-related genes and from clinical trials evaluating the efficacy of Angiotensin II Type 1 (AT1) receptor antagonists and angiotensin converting enzyme inhibitors in migraine prophylaxis. RAS seems to play a role in the pathophysiology of migraine, but more direct evidence is still missing.

Idioma originalEnglish (US)
Páginas (desde-hasta)512-519
Número de páginas8
PublicaciónProtein and Peptide Letters
Volumen27
N.º6
DOI
EstadoPublished - 2020
Publicado de forma externa

ASJC Scopus subject areas

  • Structural Biology
  • Biochemistry

Huella

Profundice en los temas de investigación de 'Renin-angiotensin-aldosterone system and migraine: A systematic review of human studies'. En conjunto forman una huella única.

Citar esto